Concentrix (NASDAQ: CNXC) grows Q1 revenue but profit, cash flow weaken
Concentrix (NASDAQ: CNXC) reported a 5.4% increase in Q1 revenue to $2.5 billion, driven by strength in retail, travel, e-commerce, banking, and communications sectors. However, the company's profit significantly declined, with net income falling to $21.6 million from $70.3 million a year earlier, and operating cash flow swung to an outflow of $83.2 million. This decline was attributed to gross margin compression, increased restructuring and integration expenses, a loss on assets held for sale, and substantial long-term debt.
Concentrix Corp. Experiences Revision in Its Stock Evaluation Amidst Market Challenges
Concentrix Corp. has seen a substantial decline in its stock value, dropping 59.38% over the past year, in sharp contrast to the S&P 500's gains. Technical indicators uniformly suggest a bearish outlook for the company, reflecting significant struggles to regain market traction amidst a challenging economic landscape. The stock has experienced even steeper declines over three and five-year periods.
Concentrix (CNXC) CEO Christopher Caldwell adds 1,000 shares
Concentrix Corp's President and CEO, Christopher A. Caldwell, purchased 1,000 shares of company common stock on March 26, 2026, at an average price of $26.97 per share in an open-market transaction. This purchase increases his direct ownership to 357,382 shares, signaling enhanced insider confidence in the company. The transaction was disclosed through a Form 4 filing with the SEC, which provides transparency into insider trading activities.
Concentrix (CNXC) director awarded 7,701 restricted stock units
Concentrix (CNXC) director Hayley Kathryn was awarded 7,701 restricted stock units under the company's 2020 Stock Incentive Plan. These units, granted at no cash cost, will vest on the earlier of one year from the grant date or the company’s 2027 Annual Meeting of Stockholders. After this transaction, Kathryn directly holds 17,712.1206 shares and indirectly holds 3,034.2930 shares through a trust.
Concentrix (NASDAQ: CNXC) director receives 7,701-share restricted stock award
Jennifer Deason, a director at Concentrix (NASDAQ: CNXC), received an award of 7,701 restricted stock units (RSUs) as compensation, increasing her direct holdings to 17,704 shares. The RSUs were granted under the 2020 Stock Incentive Plan with no cash purchase price and will vest on the earlier of one year from the grant date or Concentrix’s 2027 Annual Meeting of Stockholders. This transaction is categorized as a compensation-related grant rather than an open-market purchase.
Concentrix (CNXC) director Ann Vezina receives 7,701 RSU equity grant
Concentrix director Ann F. Vezina was granted 7,701 shares of Common Stock in the form of restricted stock units (RSUs) as part of the company's 2020 Stock Incentive Plan. This award, made at no cash price, increases her direct holdings to 19,648 shares. The RSUs will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.
Concentrix Corp (CNXC) director Cheng Chih-Kai submits initial Form 3
Concentrix Corp director Cheng Chih-Kai has filed an initial Form 3, signaling his new status as an insider director of the company. This administrative filing does not indicate any beneficial ownership of securities, nor does it reflect any trading activity such as purchases, sales, or derivative exercises. The document primarily serves as an initial disclosure required by the SEC for new insiders.
Concentrix (CNXC) director LaVerne Council receives 7,701-share RSU award
Concentrix (CNXC) director LaVerne H. Council was granted 7,701 Restricted Stock Units (RSUs) as an equity award, increasing her direct holdings to 17,704 shares. These RSUs were issued at no cash exercise price and are set to vest on the earlier of the one-year anniversary of the grant date or the company's 2027 Annual Meeting of Stockholders. This award aligns director compensation with the long-term interests of shareholders.
Restricted stock grant increases Concentrix (NASDAQ: CNXC) director stake
Concentrix (NASDAQ: CNXC) director Bilge Ogut received a grant of 7,701 restricted stock units, as detailed in a recent Form 4 SEC filing. These units are an equity-based compensation and vest fully on the earlier of one year from the grant date or Concentrix's 2027 Annual Meeting. Following this award, Ogut directly holds 7,701 shares, aligning her interests with shareholders.
Cheng Chih-Kai receives 7,701 Concentrix Corp (CNXC) restricted stock units
Concentrix Corp director Cheng Chih-Kai was granted 7,701 restricted stock units (RSUs) of Common Stock at no cash purchase price, under the company’s 2020 Stock Incentive Plan. This award represents his entire direct holding after the transaction and is compensation-related, not an open-market purchase or sale. The RSUs will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix Corp's 2027 Annual Meeting of Stockholders.
Concentrix (NASDAQ: CNXC) investors approve 3.7M-share increase to 2020 stock plan
Concentrix (NASDAQ: CNXC) stockholders approved an amendment to the 2020 Stock Incentive Plan, increasing the number of shares available for issuance by 3,700,000. Additionally, shareholders elected nine directors, ratified Ernst & Young LLP as the independent auditor for fiscal year 2026, and approved the compensation of named executive officers on an advisory basis. These decisions were made at the company's 2026 annual meeting on March 25, 2026.
Vanguard realigns reporting; Concentrix (CNXC) ownership shown as 0 shares
The Vanguard Group has filed an amended Schedule 13G/A report for Concentrix Corp (CNXC), indicating 0 shares beneficially owned due to an internal realignment effective January 12, 2026. This administrative change means certain Vanguard subsidiaries will now report their beneficial ownership separately in accordance with SEC guidelines. The filing clarifies reporting attribution rather than describing a market transaction or sale of shares.
Concentrix Corp. Hits New 52-Week Low at $24.28 Amid Declining Confidence
Concentrix Corp. (CNXC) has hit a new 52-week low of $24.28, reflecting a significant 56.5% stock price decline over the past year. Despite consistent growth in net sales and operating profit, the company faces challenges including a high debt-to-equity ratio and a 13.18% reduction in promoter stake, indicating declining confidence. The company currently has a market capitalization of $1,972 million and a P/E ratio of 6.00.
Concentrix Corporation (NASDAQ:CNXC) Q1 2026 Earnings Call Transcript
Concentrix Corporation (NASDAQ:CNXC) reported Q1 2026 earnings, missing EPS expectations at $2.61 against an anticipated $2.65. Despite the slight miss, the company highlights significant growth in AI-driven solutions, with a 61% year-over-year increase in technology wins and a doubling of annual contract value for AI solutions quarter-on-quarter. The outlook for Q2 anticipates revenue between $2.46 billion and $2.485 billion, with executives expressing confidence in margin expansion in the latter half of 2026 and a commitment to reducing net leverage.
Concentrix Corporation (CNXC) Lags Q1 Earnings Estimates
Concentrix Corporation (CNXC) reported Q1 earnings of $2.61 per share, missing the Zacks Consensus Estimate of $2.64 per share. Despite the earnings miss, the company's revenues of $2.5 billion surpassed the Zacks Consensus Estimate by 0.51%. Concentrix shares have declined by 20.5% year-to-date, and the stock currently holds a Zacks Rank #3 (Hold).
These Analysts Cut Their Forecasts On Concentrix Following Q1 Results
Following its Q1 results, which showed mixed financial performance, Concentrix (NASDAQ: CNXC) has seen several analysts cut their price targets. Despite revenue slightly beating estimates, adjusted EPS missed, and the company issued Q2 guidance below expectations, leading to a 6.9% drop in its share price. Analysts from Baird, Canaccord Genuity, and Barrington Research maintained their ratings but significantly lowered their price targets for Concentrix.
BofA cuts Concentrix stock price target on margin pressure concerns
BofA Securities has lowered its price target for Concentrix Corp. (NASDAQ:CNXC) to $32 from $47 due to expected margin pressure, while maintaining a Neutral rating. The company's first-quarter revenue met the high end of guidance, but EPS of $2.61 fell short of BofA's estimates. Concentrix issued second-quarter guidance that was below Street expectations, and the stock is currently trading near its 52-week low.
Concentrix Corporation (NASDAQ:CNXC) to Issue Quarterly Dividend of $0.36
Concentrix Corporation (NASDAQ:CNXC) announced a quarterly dividend of $0.36 per share, to be paid on May 5th to shareholders of record on April 24th, representing a 5.4% yield and an 11.3% payout ratio. Despite revenue growth of 5.4% year-over-year in Q1 2026, the company experienced a significant decline in GAAP net income (down 69% YoY) and missed non-GAAP EPS estimates slightly, leading to a sharp sell-off in shares. The company highlighted ongoing share repurchases and commercial momentum in higher-value offerings, but also noted weakened profitability, compressed margins, and negative cash flow.
Canaccord cuts Concentrix stock price target on margin pressure
Canaccord has lowered its price target for Concentrix Corp. (NASDAQ:CNXC) to $55 from $80, while maintaining a Buy rating, due to margin compression and the market's skepticism about the company's second-half recovery promises. The company reported slightly lower-than-expected EPS but met revenue expectations for Q1 fiscal year 2026, with adjusted EBITDA margins compressing by about 200 basis points year-over-year. Despite the stock's significant decline, it trades at an attractive EV/EBITDA of 5.03, and the firm views the first quarter's performance as largely in-line with expectations.
Core & Main, Concentrix And 3 Stocks To Watch Heading Into Tuesday
As U.S. stock futures showed a downward trend on a Tuesday morning, several companies including Core & Main, Concentrix, and GameStop are in focus for investors. Core & Main and Concentrix are expected to release their quarterly earnings, while Slide Insurance Holdings announced a new share buyback program. Applied Optoelectronics received a significant order from a major hyperscaler.
Concentrix Corp (CNXC) Q1 2026 Earnings Call Highlights: Strong AI Adoption and Banking Growth
Concentrix Corp (CNXC) reported a 1.9% constant currency revenue increase and a 61% jump in technology wins for Q1 2026, with AI-related bookings more than doubling and banking revenue up 13%. Despite strong AI adoption and growth in banking, the company experienced a negative free cash flow of $145 million due to increased accounts receivable and margin compression in some verticals. Concentrix projects margin improvement in the second half of the year through cost actions and scale from transformational deals.
Concentrix Corp (NASDAQ:CNXC) Stock Plummets on Earnings Miss and Cautious Guidance
Concentrix Corporation (NASDAQ:CNXC) reported Q1 fiscal 2026 results that met its internal guidance but missed Wall Street estimates for revenue and non-GAAP EPS. The company experienced a significant year-over-year decline in GAAP profitability and provided cautious guidance for Q2 and the full fiscal year, which fell below analyst expectations. This led to a sharp negative market reaction, with the stock plummeting due to investor concerns about earnings and the conservative outlook.
Concentrix reports Q1 FY2026: Revenue $2.50B, Adjusted diluted EPS $2.61
Concentrix reported its Q1 fiscal year 2026 results, with revenue reaching $2.50 billion and adjusted diluted EPS of $2.61. The company achieved GAAP net income of $21.6 million and diluted GAAP EPS of $0.33. Concentrix maintained its full-year outlook, emphasizing its focus on AI-driven solutions and enterprise wins, and highlighted strong revenue growth in retail, travel & e-commerce, and banking, financial services & insurance segments.
Concentrix (NASDAQ: CNXC) Q1 2026 revenue grows as earnings and cash flow weaken
Concentrix (NASDAQ: CNXC) reported mixed Q1 2026 results, with revenue increasing by 5.4% year-on-year to $2,500.4 million, but GAAP net income and diluted EPS saw significant declines. Cash flow from operations and adjusted free cash flow were negative for the quarter. Despite the weaker earnings and cash flow, the company maintained its full-year 2026 guidance, expecting low-single-digit constant-currency revenue growth and positive adjusted free cash flow of $630-$650 million.
Concentrix Corp - Amendment Increases Lender Commitment To $750 Million From $700 Million - SEC Filing
Concentrix Corp announced via an SEC filing that an amendment has been made to increase lender commitment from $700 million to $750 million. The information was reported by Refinitiv and Reuters.
Concentrix (NASDAQ: CNXC) extends and lifts $750M receivables facility
Concentrix Corporation (NASDAQ: CNXC) has amended its accounts receivable securitization facility, increasing the borrowing capacity from $700 million to $750 million and extending the termination date from January 14, 2027, to March 20, 2028. This amendment provides the company with greater flexibility for funding working capital secured by receivables. The agreement involves Concentrix as servicer, Concentrix Receivables, Inc. as borrower, and PNC Bank, National Association as administrative agent.
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Concentrix Corp has revised its existing securitization financing arrangement.
Concentrix Corp has revised its securitization financing arrangement, extending the termination date to March 20, 2028. This move, reported in an SEC filing, aims to provide stable funding and optimize the company's capital structure. The article also includes a disclaimer that its content is solely the author's opinion and not investment advice.
Concentrix earnings up next as AI investments meet reality By Investing.com
Concentrix Corp. is set to report its first-quarter fiscal 2026 results, with analysts expecting declines in EPS and revenue sequentially, but a year-over-year revenue increase. The report will assess whether the company's AI investments can counteract growth challenges and client spending caution in the competitive customer experience outsourcing market. Despite a recent beat on prior-quarter expectations, shares have fallen, trading near a 52-week low.
Earnings To Watch: Concentrix (CNXC) Reports Q1 Results Tomorrow
Concentrix (CNXC), a customer experience solutions provider, is set to report its Q1 earnings tomorrow morning. The market anticipates a 5% year-on-year revenue growth, turning around from last year's decrease, despite the company missing full-year and next quarter EPS guidance last quarter. Concentrix's stock has performed positively, up 8.3% over the last month, against a 1.4% average decline for its sector peers.
Earnings To Watch: Concentrix (CNXC) Reports Q1 Results Tomorrow
Concentrix (NASDAQ:CNXC) is set to announce its Q1 earnings results this Tuesday morning. The company beat revenue expectations last quarter but significantly missed full-year and next-quarter EPS guidance. Analysts generally anticipate 5% year-on-year revenue growth for Q1, a reversal from a previous decrease, and Concentrix has a track record of exceeding Wall Street's expectations.
Mid-Cap valuation leaders: Concentrix at 2.7x forward P/E (IJH:NYSEARCA)
Mid-cap U.S. stocks have been under modest pressure recently due to broader market caution. This article highlights top mid-cap stocks with low forward P/E ratios, with Concentrix Corporation leading at 2.7x, followed by Brighthouse Financial and DXC Technology. These companies generally hold strong valuation grades.
Concentrix (Nasdaq:CNXC) - Stock Analysis
Concentrix (Nasdaq:CNXC) is trading significantly below its estimated fair value, with analysts forecasting strong earnings growth of 127.65% per year. Despite this, the company faces risks related to interest payment coverage and dividend coverage. The stock has underperformed both the US Professional Services industry and the broader US market over the past year.
Concentrix (CNXC) Expected to Announce Earnings on Tuesday
Concentrix (NASDAQ:CNXC) is scheduled to release its Q1 2026 earnings before market open on Tuesday, March 24th, with analysts anticipating earnings per share of $2.64 and revenue of $2.4906 billion. The company has provided Q1 2026 EPS guidance of $2.57-$2.69 and full-year 2026 EPS guidance of $11.48-$12.07. Despite beating previous quarter estimates, Concentrix faces margin pressure, high debt, and analysts currently hold a "Hold" rating with an average price target of $63.75.
Concentrix Corp Stock (ISIN: US20602D1019) Trades at Steep Discount Amid Geopolitical Pressures and Margin Rebuild Hopes
Concentrix Corp stock is trading at a significant discount, around $31.67, with analysts foreseeing up to 41% upside to price targets of $66.25. This undervaluation is attributed to geopolitical pressures causing a sector-wide sell-off and a heavy debt load, yet hopes for margin expansion from Webhelp merger synergies remain. The company's Q1 2026 earnings release on March 24th is a key catalyst to watch for validation of synergy progress and debt reduction.
Concentrix, EXL, Genpact, Robert Half, and Accenture Shares Are Falling, What You Need To Know
Shares of Concentrix, EXL, Genpact, Robert Half, and Accenture experienced declines after reports of escalating geopolitical tensions in the Middle East led to a "risk-off" sentiment among investors. Despite the U.S. President's assurances, the market reacted negatively, pushing investors to sell equities. This event created potential buying opportunities for high-quality stocks amidst the overreaction to geopolitical news.
CNXC Earnings History & Surprises | EPS & Revenue Results | CONCENTRIX CORP (NASDAQ:CNXC)
This article provides a detailed historical overview of CONCENTRIX CORP (CNXC) quarterly earnings, including EPS and revenue actuals, analyst estimates, and surprise percentages. It highlights the company's past performance, upcoming earnings date, and beat rates. The analysis section summarizes CNXC's performance against estimates over the last four quarters.
Concentrix Corporation Announces First Quarter 2026 Financial Results Release and Conference Call Schedule
Concentrix Corporation announced it will release its first quarter 2026 financial results on March 24, 2026, before market open. The company will also host a conference call and webcast at 8:30 a.m. Eastern Time on the same day to discuss the results and answer analyst questions. Concentrix, a Fortune 500 company, provides technology and services to over 2,000 clients globally.
Concentrix sets March 24 date to reveal Q1 2026 results
Concentrix (NASDAQ: CNXC) has announced it will release its first quarter 2026 financial results before market open on Tuesday, March 24, 2026. The company will also host a conference call and webcast at 8:30 a.m. Eastern Time on the same day to discuss the results and answer analyst questions. This announcement aligns with Concentrix's historical pattern of scheduling earnings releases, which has typically led to modest positive market reactions.
Concentrix stock hits 52-week low at 31.62 USD By Investing.com
Concentrix Corp's stock has fallen to a new 52-week low of $31.62, representing a 48% decline from its high and a 33.27% drop over the last year. Despite not being profitable in the past twelve months, analysts project profitability for the current year with an EPS forecast of $11.77. The company's recent Q4 2025 earnings surpassed expectations, yet BofA Securities lowered its price target due to margin pressure.
Concentrix Corporation (CNXC) Partners With Proofpoint to Boost Cybersecurity
Concentrix Corporation (NASDAQ: CNXC) has announced a partnership with Proofpoint to enhance cybersecurity services across the Asia Pacific region. This collaboration integrates Proofpoint's human-focused security tools with Concentrix's Security Operations Centers and regional expertise. The goal is to provide improved cybersecurity solutions, especially amidst growing cloud adoption and AI integration, by making it easier for customers to protect their people, data, and communications.
Concentrix Corporation (CNXC) Partners With Proofpoint to Boost Cybersecurity
Concentrix Corporation (NASDAQ:CNXC) has partnered with Proofpoint to enhance cybersecurity services across the Asia Pacific region. This collaboration integrates Proofpoint’s human-focused security tools with Concentrix’s Security Operations Centers to offer improved cybersecurity solutions, particularly in light of increased cloud adoption and AI. The partnership aims to provide customers with better monitoring and protection of data and communications, with joint sales efforts in APAC markets.
Concentrix (NASDAQ:CNXC) Trading 10.2% Higher - Should You Buy?
Concentrix (NASDAQ:CNXC) shares surged 10.2% on Thursday, reaching $34.44 despite lower trading volume. The company has mixed analyst ratings (Hold average, $63.75 price target) and key financial metrics including a $1.97 billion market cap, negative net margin, and a 4.5% dividend yield. CEO Christopher Caldwell recently increased his stake in the company.
CNXC Technical Analysis & ETF Price Forecast
This article provides a technical analysis of Concentrix Corp (CNXC), indicating a "Neutral" overall technical sentiment. It details various technical indicators such as MACD, RSI, and moving averages, noting that many values are currently undefined. The analysis also covers support and resistance levels, which are also currently listed as undefined.
Concentrix Corp. Stock Hits Day Low of $29.55 Amid Price Pressure
Concentrix Corp. stock fell by 7.37% to an intraday low of $29.55, reflecting significant market challenges and underperformance against the S&P 500 over the past year. The company's year-to-date loss stands at 26.82%, and promoter confidence has decreased, with a 13.18% reduction in their stake. Financial metrics show a P/E ratio of 8.00 and a 4.32% dividend yield, but also a high debt-to-equity ratio of 1.59.
Concentrix (CNXC) sells $600M notes and redeems $600M 2026 bonds
Concentrix Corporation issued $600 million in 6.500% Senior Notes due 2029 through a registered public offering. The company utilized these proceeds, alongside other funds, to redeem $600 million of its existing 6.650% Senior Notes that were set to mature on August 2, 2026. This financial maneuver effectively refinances a portion of Concentrix's debt, extending maturity and adjusting interest rates.
CNXC Stock Price, Forecast & Analysis | CONCENTRIX CORP (NASDAQ:CNXC)
This article provides an analysis of Concentrix Corp (NASDAQ: CNXC), including its stock price, technical and fundamental ratings, financial highlights, and analyst forecasts. The stock currently trades at $32.54, with analysts predicting a 77.89% price increase over the next year. Key statistics, performance data, and competitor analysis are also presented.
Envestnet Asset Management Inc. Grows Position in Concentrix Corporation $CNXC
Envestnet Asset Management Inc. increased its stake in Concentrix Corporation by 18.5% in the third quarter, bringing its total holdings to 260,715 shares valued at approximately $12.03 million. Other institutional investors also adjusted their positions, with overall institutional ownership at about 90.34%. Despite a negative net margin and high debt, Concentrix reported a slight EPS beat and announced a quarterly dividend, while analysts' ratings are mixed.
CNXC SEC Filings - Concentrix 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Concentrix (CNXC) SEC filings, including annual 10-K reports, quarterly 10-Q reports, 8-K material event forms, and insider trading documents. It offers AI-powered summaries and real-time updates from the EDGAR system. The article details several recent filings, such as an insider sale, quarterly financial statements (10-Q), CEO stock transactions, Form 144 filings, and AQR Capital's significant holding.
Concentrix Corp Announces $600 Million Senior Notes Offering
Concentrix Corp announced a $600 million senior notes offering due 2029, with the pricing set at 6.500%. The proceeds from this offering will be used to redeem $600 million of existing 6.650% notes due in 2026, aiming to optimize the company's debt structure and costs. BofA Securities and J.P. Morgan are leading the underwriting for the offering, which is expected to close on February 24, 2026.
Form DEF 14A Concentrix Corp For: Mar 25
Concentrix Corporation has filed its DEF 14A proxy statement for its Annual Meeting of Stockholders on March 25, 2026. Key proposals include the election of nine directors, ratification of Ernst & Young LLP as the independent auditor, an advisory vote on executive compensation, and approval of an amendment to the 2020 Stock Incentive Plan to increase shares available for issuance. The document also details fiscal year 2025 financial highlights, executive compensation, and corporate governance practices.
